AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
As of today, AstraZeneca(AZN) shares are valued at $184.26. The company's market cap stands at 286.28B, with a P/E ratio of 27.09 and a dividend yield of 1.7%.
On 2026-05-18, AstraZeneca(AZN) stock moved within a range of $181.76 to $184.56. With shares now at $184.26, the stock is trading +1.4% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 623.74K, compared to an average daily volume of 1.81M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $136.16.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $136.16.
AZN News
AstraZeneca Secures FDA Approval For Baxfendy In Hypertension The company also announced expanded FDA approvals for Enhertu in HER2-positive early breast cance...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
AstraZeneca’s (AZN) BAXFENDY has been approved in the US as a first-in-class aldosterone synthase inhibitor for the treatment of hypertension in combination wit...
Analyst ratings
81%
of 31 ratingsMore AZN News
Reports Q1 revenue $2.2M vs. $2.3M last year. Compugen (CGEN) expects that its cash and cash-related balances will be sufficient to fund its operating plans int...
AstraZeneca’s (AZN) shares edged lower early Monday despite the British pharma giant securing approval for its Baxfendy (baxdrostat) blood pressure pill. The dr...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
The approval expands AstraZeneca’s cardiovascular, renal and metabolism portfolio. Rachel Wisniewski / Reuters AstraZeneca AZN -0.79 %decrease; red down pointi...
The study compared the regimen against standard treatment involving radical cystectomy, with or without approved adjuvant therapy. The European drug giant said...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.